Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.72 HKD | +1.41% | -6.49% | -20.00% |
Apr. 01 | PuraPharm's Net Loss Shrinks in 2023; Revenue Falls 9% | MT |
Mar. 28 | PuraPharm Corporation Limited Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Business Summary
Number of employees: 662
Sales per Business
HKD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Hong Kong Concentrated Chinese Medicine Granules
51.2
%
| 192 | 42.9 % | 208 | 51.2 % | +8.50% |
Chinese Healthcare Products
20.2
%
| 79 | 17.6 % | 82 | 20.2 % | +3.97% |
Clinics
13.2
%
| 46 | 10.3 % | 54 | 13.2 % | +16.51% |
China Concentrated Chinese Medicine Granules
12.5
%
| 118 | 26.3 % | 51 | 12.5 % | -56.85% |
Plantation
2.9
%
| 13 | 3.0 % | 12 | 2.9 % | -10.14% |
Sales per region
HKD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Hong Kong
75.0
%
| 282 | 62.8 % | 305 | 75.0 % | +8.44% |
China
15.5
%
| 132 | 29.5 % | 63 | 15.5 % | -52.48% |
Other Countries/Regions
9.5
%
| 34 | 7.6 % | 39 | 9.5 % | +13.06% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Yu Ling Chan
CEO | Chief Executive Officer | 63 | 98-05-04 |
Hang Woon Ma
SAM | Sales & Marketing | - | - |
Pui Hung
HRO | Human Resources Officer | - | - |
Kwun Kiu Cheung
AUD | Comptroller/Controller/Auditor | 38 | 20-12-31 |
Yuk Chun Ho
SAM | Sales & Marketing | 56 | 04-12-31 |
Qiong Ruan
PRN | Corporate Officer/Principal | 46 | - |
Charmayne Chan
SEC | Corporate Secretary | - | 21-07-30 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Kwok Wah Ho
BRD | Director/Board Member | 65 | 15-06-11 |
Lim Kin Leung
BRD | Director/Board Member | 70 | 15-06-11 |
Yu Ling Chan
CEO | Chief Executive Officer | 63 | 98-05-04 |
Lap-Chee Tsui
BRD | Director/Board Member | 73 | 15-06-11 |
Yee Wai Man
BRD | Director/Board Member | 58 | 97-12-31 |
Kwok Keung Leung
BRD | Director/Board Member | 68 | 23-06-13 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 395,897,275 | 186,308,134 ( 47.06 %) | 0 | 47.06 % |
Company contact information
PuraPharm Corp. Ltd.
Unit 201–207, 2/F Wireless Centre, Phase One
, Hong Kong
+
http://www.purapharm.comSector
Sales per Business
Sales per region
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-20.00% | 35.9M | |
+39.50% | 6.11B | |
-21.15% | 4.19B | |
+5.32% | 3.28B | |
-18.39% | 2.86B | |
-6.41% | 2.41B | |
+42.43% | 1.9B | |
-4.27% | 1.57B | |
-14.15% | 1.56B | |
-15.57% | 1.48B |
- Stock Market
- Equities
- 1498 Stock
- Company PuraPharm Corporation Limited